Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NFATC4
|
ENSG00000100968.9 | NFATC4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NFATC4 | hg19_v2_chr14_+_24837226_24837547 | 0.25 | 5.4e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_+_102104980 | 3.49 |
ENST00000545560.2 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
chr14_-_92413353 | 2.58 |
ENST00000556154.1 |
FBLN5 |
fibulin 5 |
chr1_-_57045228 | 2.41 |
ENST00000371250.3 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
chr2_-_190044480 | 2.34 |
ENST00000374866.3 |
COL5A2 |
collagen, type V, alpha 2 |
chr1_+_163038565 | 2.34 |
ENST00000421743.2 |
RGS4 |
regulator of G-protein signaling 4 |
chr14_-_30396948 | 2.22 |
ENST00000331968.5 |
PRKD1 |
protein kinase D1 |
chr2_+_189839046 | 2.03 |
ENST00000304636.3 ENST00000317840.5 |
COL3A1 |
collagen, type III, alpha 1 |
chr8_-_120685608 | 1.91 |
ENST00000427067.2 |
ENPP2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr2_+_152214098 | 1.78 |
ENST00000243347.3 |
TNFAIP6 |
tumor necrosis factor, alpha-induced protein 6 |
chr14_-_30396802 | 1.71 |
ENST00000415220.2 |
PRKD1 |
protein kinase D1 |
chr2_-_238322800 | 1.63 |
ENST00000392004.3 ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3 |
collagen, type VI, alpha 3 |
chr2_-_238323007 | 1.60 |
ENST00000295550.4 |
COL6A3 |
collagen, type VI, alpha 3 |
chr2_-_238322770 | 1.60 |
ENST00000472056.1 |
COL6A3 |
collagen, type VI, alpha 3 |
chr12_-_47219733 | 1.50 |
ENST00000547477.1 ENST00000447411.1 ENST00000266579.4 |
SLC38A4 |
solute carrier family 38, member 4 |
chr8_+_17434689 | 1.50 |
ENST00000398074.3 |
PDGFRL |
platelet-derived growth factor receptor-like |
chr6_-_152639479 | 1.30 |
ENST00000356820.4 |
SYNE1 |
spectrin repeat containing, nuclear envelope 1 |
chrX_+_86772787 | 1.25 |
ENST00000373114.4 |
KLHL4 |
kelch-like family member 4 |
chr13_-_33859819 | 1.21 |
ENST00000336934.5 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
chr1_+_162602244 | 1.18 |
ENST00000367922.3 ENST00000367921.3 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
chr12_-_56106060 | 1.14 |
ENST00000452168.2 |
ITGA7 |
integrin, alpha 7 |
chr1_+_164528866 | 1.13 |
ENST00000420696.2 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
chr6_-_167275991 | 1.12 |
ENST00000510118.1 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
chr5_-_124081008 | 1.09 |
ENST00000306315.5 |
ZNF608 |
zinc finger protein 608 |
chr6_-_167276033 | 1.09 |
ENST00000503859.1 ENST00000506565.1 |
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
chr3_+_69812877 | 1.07 |
ENST00000457080.1 ENST00000328528.6 |
MITF |
microphthalmia-associated transcription factor |
chr8_+_70404996 | 1.05 |
ENST00000402687.4 ENST00000419716.3 |
SULF1 |
sulfatase 1 |
chr7_+_20687017 | 1.04 |
ENST00000258738.6 |
ABCB5 |
ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
chr8_-_13372253 | 1.03 |
ENST00000316609.5 |
DLC1 |
deleted in liver cancer 1 |
chr2_-_179343268 | 0.99 |
ENST00000424785.2 |
FKBP7 |
FK506 binding protein 7 |
chrX_+_86772707 | 0.98 |
ENST00000373119.4 |
KLHL4 |
kelch-like family member 4 |
chr8_-_57123815 | 0.97 |
ENST00000316981.3 ENST00000423799.2 ENST00000429357.2 |
PLAG1 |
pleiomorphic adenoma gene 1 |
chr2_-_179343226 | 0.94 |
ENST00000434643.2 |
FKBP7 |
FK506 binding protein 7 |
chr20_+_12989596 | 0.93 |
ENST00000434210.1 ENST00000399002.2 |
SPTLC3 |
serine palmitoyltransferase, long chain base subunit 3 |
chr14_+_21156915 | 0.92 |
ENST00000397990.4 ENST00000555597.1 |
ANG RNASE4 |
angiogenin, ribonuclease, RNase A family, 5 ribonuclease, RNase A family, 4 |
chr1_+_78470530 | 0.92 |
ENST00000370763.5 |
DNAJB4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
chr5_+_82767284 | 0.88 |
ENST00000265077.3 |
VCAN |
versican |
chr4_-_70626314 | 0.88 |
ENST00000510821.1 |
SULT1B1 |
sulfotransferase family, cytosolic, 1B, member 1 |
chr12_+_51318513 | 0.81 |
ENST00000332160.4 |
METTL7A |
methyltransferase like 7A |
chr10_-_62704005 | 0.80 |
ENST00000337910.5 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
chr1_-_145470383 | 0.80 |
ENST00000369314.1 ENST00000369313.3 |
POLR3GL |
polymerase (RNA) III (DNA directed) polypeptide G (32kD)-like |
chr14_-_89883412 | 0.79 |
ENST00000557258.1 |
FOXN3 |
forkhead box N3 |
chr11_+_19799327 | 0.77 |
ENST00000540292.1 |
NAV2 |
neuron navigator 2 |
chr7_-_19157248 | 0.76 |
ENST00000242261.5 |
TWIST1 |
twist family bHLH transcription factor 1 |
chr4_-_1670632 | 0.76 |
ENST00000461064.1 |
FAM53A |
family with sequence similarity 53, member A |
chr14_+_29236269 | 0.73 |
ENST00000313071.4 |
FOXG1 |
forkhead box G1 |
chrX_+_22056165 | 0.73 |
ENST00000535894.1 |
PHEX |
phosphate regulating endopeptidase homolog, X-linked |
chr20_+_33292068 | 0.72 |
ENST00000374810.3 ENST00000374809.2 ENST00000451665.1 |
TP53INP2 |
tumor protein p53 inducible nuclear protein 2 |
chr1_+_164529004 | 0.71 |
ENST00000559240.1 ENST00000367897.1 ENST00000540236.1 ENST00000401534.1 |
PBX1 |
pre-B-cell leukemia homeobox 1 |
chr3_+_154797428 | 0.70 |
ENST00000460393.1 |
MME |
membrane metallo-endopeptidase |
chr3_-_112329110 | 0.69 |
ENST00000479368.1 |
CCDC80 |
coiled-coil domain containing 80 |
chr7_+_18535854 | 0.68 |
ENST00000401921.1 |
HDAC9 |
histone deacetylase 9 |
chr4_-_107957454 | 0.68 |
ENST00000285311.3 |
DKK2 |
dickkopf WNT signaling pathway inhibitor 2 |
chr14_+_29234870 | 0.67 |
ENST00000382535.3 |
FOXG1 |
forkhead box G1 |
chr3_-_18480260 | 0.67 |
ENST00000454909.2 |
SATB1 |
SATB homeobox 1 |
chr11_-_96076334 | 0.66 |
ENST00000524717.1 |
MAML2 |
mastermind-like 2 (Drosophila) |
chr2_-_175712270 | 0.66 |
ENST00000295497.7 ENST00000444394.1 |
CHN1 |
chimerin 1 |
chr18_+_66465302 | 0.65 |
ENST00000360242.5 ENST00000358653.5 |
CCDC102B |
coiled-coil domain containing 102B |
chr1_+_36789335 | 0.65 |
ENST00000373137.2 |
RP11-268J15.5 |
RP11-268J15.5 |
chrX_+_9431324 | 0.64 |
ENST00000407597.2 ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X |
transducin (beta)-like 1X-linked |
chr10_-_33623564 | 0.64 |
ENST00000374875.1 ENST00000374822.4 |
NRP1 |
neuropilin 1 |
chr2_+_23608064 | 0.64 |
ENST00000486442.1 |
KLHL29 |
kelch-like family member 29 |
chr7_-_92777606 | 0.63 |
ENST00000437805.1 ENST00000446959.1 ENST00000439952.1 ENST00000414791.1 ENST00000446033.1 ENST00000411955.1 ENST00000318238.4 |
SAMD9L |
sterile alpha motif domain containing 9-like |
chr16_+_2039946 | 0.62 |
ENST00000248121.2 ENST00000568896.1 |
SYNGR3 |
synaptogyrin 3 |
chr9_+_92219919 | 0.62 |
ENST00000252506.6 ENST00000375769.1 |
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
chr1_-_85870177 | 0.62 |
ENST00000542148.1 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
chr1_+_79115503 | 0.59 |
ENST00000370747.4 ENST00000438486.1 ENST00000545124.1 |
IFI44 |
interferon-induced protein 44 |
chr11_+_65190245 | 0.57 |
ENST00000499732.1 ENST00000501122.2 ENST00000601801.1 |
NEAT1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
chr2_-_101767715 | 0.55 |
ENST00000376840.4 ENST00000409318.1 |
TBC1D8 |
TBC1 domain family, member 8 (with GRAM domain) |
chr3_+_46618727 | 0.55 |
ENST00000296145.5 |
TDGF1 |
teratocarcinoma-derived growth factor 1 |
chr16_-_73093597 | 0.55 |
ENST00000397992.5 |
ZFHX3 |
zinc finger homeobox 3 |
chr11_+_77532155 | 0.54 |
ENST00000532481.1 ENST00000526415.1 ENST00000393427.2 ENST00000527134.1 ENST00000304716.8 |
AAMDC |
adipogenesis associated, Mth938 domain containing |
chr3_-_114790179 | 0.54 |
ENST00000462705.1 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr11_+_77532233 | 0.53 |
ENST00000525409.1 |
AAMDC |
adipogenesis associated, Mth938 domain containing |
chr2_+_201994569 | 0.53 |
ENST00000457277.1 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
chr15_+_62853562 | 0.52 |
ENST00000561311.1 |
TLN2 |
talin 2 |
chr2_+_201994042 | 0.52 |
ENST00000417748.1 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
chr1_-_155881156 | 0.52 |
ENST00000539040.1 ENST00000368323.3 |
RIT1 |
Ras-like without CAAX 1 |
chr7_+_120628731 | 0.50 |
ENST00000310396.5 |
CPED1 |
cadherin-like and PC-esterase domain containing 1 |
chr18_-_60987220 | 0.50 |
ENST00000398117.1 |
BCL2 |
B-cell CLL/lymphoma 2 |
chr6_-_53530474 | 0.50 |
ENST00000370905.3 |
KLHL31 |
kelch-like family member 31 |
chr2_+_27301435 | 0.50 |
ENST00000380320.4 |
EMILIN1 |
elastin microfibril interfacer 1 |
chr20_+_18125727 | 0.49 |
ENST00000489634.2 |
CSRP2BP |
CSRP2 binding protein |
chr14_-_74551096 | 0.48 |
ENST00000350259.4 |
ALDH6A1 |
aldehyde dehydrogenase 6 family, member A1 |
chr1_-_150780757 | 0.47 |
ENST00000271651.3 |
CTSK |
cathepsin K |
chr6_-_24489842 | 0.47 |
ENST00000230036.1 |
GPLD1 |
glycosylphosphatidylinositol specific phospholipase D1 |
chr6_+_155537771 | 0.46 |
ENST00000275246.7 |
TIAM2 |
T-cell lymphoma invasion and metastasis 2 |
chr19_+_30863271 | 0.45 |
ENST00000355537.3 |
ZNF536 |
zinc finger protein 536 |
chr20_+_33464238 | 0.45 |
ENST00000360596.2 |
ACSS2 |
acyl-CoA synthetase short-chain family member 2 |
chr19_-_36909528 | 0.44 |
ENST00000392161.3 ENST00000392171.1 |
ZFP82 |
ZFP82 zinc finger protein |
chr16_-_2260834 | 0.44 |
ENST00000562360.1 ENST00000566018.1 |
BRICD5 |
BRICHOS domain containing 5 |
chr6_-_15586238 | 0.44 |
ENST00000462989.2 |
DTNBP1 |
dystrobrevin binding protein 1 |
chr12_+_12938541 | 0.44 |
ENST00000356591.4 |
APOLD1 |
apolipoprotein L domain containing 1 |
chr20_-_30310693 | 0.43 |
ENST00000307677.4 ENST00000420653.1 |
BCL2L1 |
BCL2-like 1 |
chr10_-_33623310 | 0.43 |
ENST00000395995.1 ENST00000374823.5 ENST00000374821.5 ENST00000374816.3 |
NRP1 |
neuropilin 1 |
chr3_+_148545586 | 0.43 |
ENST00000282957.4 ENST00000468341.1 |
CPB1 |
carboxypeptidase B1 (tissue) |
chr3_-_114035026 | 0.43 |
ENST00000570269.1 |
RP11-553L6.5 |
RP11-553L6.5 |
chr14_-_75593708 | 0.43 |
ENST00000557673.1 ENST00000238616.5 |
NEK9 |
NIMA-related kinase 9 |
chr1_-_146082633 | 0.42 |
ENST00000605317.1 ENST00000604938.1 ENST00000339388.5 |
NBPF11 |
neuroblastoma breakpoint family, member 11 |
chr5_-_177423243 | 0.41 |
ENST00000308304.2 |
PROP1 |
PROP paired-like homeobox 1 |
chr15_-_91475747 | 0.41 |
ENST00000330334.3 ENST00000559898.1 ENST00000394272.3 |
HDDC3 |
HD domain containing 3 |
chr18_-_3247084 | 0.41 |
ENST00000609924.1 |
RP13-270P17.3 |
RP13-270P17.3 |
chr11_+_27015628 | 0.41 |
ENST00000318627.2 |
FIBIN |
fin bud initiation factor homolog (zebrafish) |
chr20_-_45985464 | 0.40 |
ENST00000458360.2 ENST00000262975.4 |
ZMYND8 |
zinc finger, MYND-type containing 8 |
chr20_-_45061695 | 0.40 |
ENST00000445496.2 |
ELMO2 |
engulfment and cell motility 2 |
chr3_-_73673991 | 0.40 |
ENST00000308537.4 ENST00000263666.4 |
PDZRN3 |
PDZ domain containing ring finger 3 |
chr20_-_45985414 | 0.39 |
ENST00000461685.1 ENST00000372023.3 ENST00000540497.1 ENST00000435836.1 ENST00000471951.2 ENST00000352431.2 ENST00000396281.4 ENST00000355972.4 ENST00000360911.3 |
ZMYND8 |
zinc finger, MYND-type containing 8 |
chr15_-_37393406 | 0.39 |
ENST00000338564.5 ENST00000558313.1 ENST00000340545.5 |
MEIS2 |
Meis homeobox 2 |
chr7_+_138943265 | 0.39 |
ENST00000483726.1 |
UBN2 |
ubinuclein 2 |
chr14_+_88471468 | 0.38 |
ENST00000267549.3 |
GPR65 |
G protein-coupled receptor 65 |
chr8_-_25281747 | 0.38 |
ENST00000421054.2 |
GNRH1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
chr20_-_45985172 | 0.38 |
ENST00000536340.1 |
ZMYND8 |
zinc finger, MYND-type containing 8 |
chr7_-_14942283 | 0.38 |
ENST00000402815.1 |
DGKB |
diacylglycerol kinase, beta 90kDa |
chrX_-_134478012 | 0.37 |
ENST00000370766.3 |
ZNF75D |
zinc finger protein 75D |
chr12_+_56511943 | 0.37 |
ENST00000257940.2 ENST00000552345.1 ENST00000551880.1 ENST00000546903.1 ENST00000551790.1 |
ZC3H10 ESYT1 |
zinc finger CCCH-type containing 10 extended synaptotagmin-like protein 1 |
chr15_+_32933866 | 0.37 |
ENST00000300175.4 ENST00000413748.2 ENST00000494364.1 ENST00000497208.1 |
SCG5 |
secretogranin V (7B2 protein) |
chr14_+_88852059 | 0.37 |
ENST00000045347.7 |
SPATA7 |
spermatogenesis associated 7 |
chr9_+_104161123 | 0.37 |
ENST00000374861.3 ENST00000339664.2 ENST00000259395.4 |
ZNF189 |
zinc finger protein 189 |
chr15_-_77712477 | 0.36 |
ENST00000560626.2 |
PEAK1 |
pseudopodium-enriched atypical kinase 1 |
chrX_-_77041685 | 0.36 |
ENST00000373344.5 ENST00000395603.3 |
ATRX |
alpha thalassemia/mental retardation syndrome X-linked |
chr14_-_74551172 | 0.36 |
ENST00000553458.1 |
ALDH6A1 |
aldehyde dehydrogenase 6 family, member A1 |
chr10_+_81838792 | 0.35 |
ENST00000372273.3 |
TMEM254 |
transmembrane protein 254 |
chrX_+_134166333 | 0.35 |
ENST00000257013.7 |
FAM127A |
family with sequence similarity 127, member A |
chr19_-_53606604 | 0.35 |
ENST00000599056.1 ENST00000599247.1 ENST00000355147.5 ENST00000429604.1 ENST00000418871.1 ENST00000599637.1 |
ZNF160 |
zinc finger protein 160 |
chr13_+_112721913 | 0.34 |
ENST00000330949.1 |
SOX1 |
SRY (sex determining region Y)-box 1 |
chrX_+_10124977 | 0.34 |
ENST00000380833.4 |
CLCN4 |
chloride channel, voltage-sensitive 4 |
chr12_-_90049828 | 0.33 |
ENST00000261173.2 ENST00000348959.3 |
ATP2B1 |
ATPase, Ca++ transporting, plasma membrane 1 |
chr1_-_113162040 | 0.33 |
ENST00000358039.4 ENST00000369668.2 |
ST7L |
suppression of tumorigenicity 7 like |
chr13_+_114462193 | 0.33 |
ENST00000375353.3 |
TMEM255B |
transmembrane protein 255B |
chr20_+_57466357 | 0.33 |
ENST00000371095.3 ENST00000371085.3 ENST00000354359.7 ENST00000265620.7 |
GNAS |
GNAS complex locus |
chr5_+_15500280 | 0.32 |
ENST00000504595.1 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
chr12_-_90049878 | 0.32 |
ENST00000359142.3 |
ATP2B1 |
ATPase, Ca++ transporting, plasma membrane 1 |
chr12_-_59314246 | 0.32 |
ENST00000320743.3 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
chr17_+_52978185 | 0.31 |
ENST00000572405.1 ENST00000572158.1 ENST00000540336.1 ENST00000572298.1 ENST00000536554.1 ENST00000575333.1 ENST00000570499.1 ENST00000572576.1 |
TOM1L1 |
target of myb1 (chicken)-like 1 |
chr1_+_99127265 | 0.31 |
ENST00000306121.3 |
SNX7 |
sorting nexin 7 |
chr4_+_26322185 | 0.31 |
ENST00000361572.6 |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
chr17_+_76311791 | 0.31 |
ENST00000586321.1 |
AC061992.2 |
AC061992.2 |
chr5_-_42811986 | 0.31 |
ENST00000511224.1 ENST00000507920.1 ENST00000510965.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chr11_-_62474803 | 0.30 |
ENST00000533982.1 ENST00000360796.5 |
BSCL2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
chr9_-_113342160 | 0.30 |
ENST00000401783.2 ENST00000374461.1 |
SVEP1 |
sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 |
chr5_+_43603229 | 0.30 |
ENST00000344920.4 ENST00000512996.2 |
NNT |
nicotinamide nucleotide transhydrogenase |
chr1_-_157670528 | 0.29 |
ENST00000368186.5 ENST00000496769.1 |
FCRL3 |
Fc receptor-like 3 |
chr6_+_64346386 | 0.29 |
ENST00000509330.1 |
PHF3 |
PHD finger protein 3 |
chr16_-_47493041 | 0.29 |
ENST00000565940.2 |
ITFG1 |
integrin alpha FG-GAP repeat containing 1 |
chr4_-_114900831 | 0.29 |
ENST00000315366.7 |
ARSJ |
arylsulfatase family, member J |
chr8_-_19459993 | 0.29 |
ENST00000454498.2 ENST00000520003.1 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
chr5_+_154238149 | 0.29 |
ENST00000519430.1 ENST00000520671.1 ENST00000521583.1 ENST00000518028.1 ENST00000519404.1 ENST00000519394.1 ENST00000518775.1 |
CNOT8 |
CCR4-NOT transcription complex, subunit 8 |
chr7_-_120498357 | 0.29 |
ENST00000415871.1 ENST00000222747.3 ENST00000430985.1 |
TSPAN12 |
tetraspanin 12 |
chr10_+_81838411 | 0.28 |
ENST00000372281.3 ENST00000372277.3 ENST00000372275.1 ENST00000372274.1 |
TMEM254 |
transmembrane protein 254 |
chr19_+_37095719 | 0.28 |
ENST00000423582.1 |
ZNF382 |
zinc finger protein 382 |
chr3_-_121740969 | 0.28 |
ENST00000393631.1 ENST00000273691.3 ENST00000344209.5 |
ILDR1 |
immunoglobulin-like domain containing receptor 1 |
chr5_+_118812237 | 0.28 |
ENST00000513628.1 |
HSD17B4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
chr11_-_47600320 | 0.28 |
ENST00000525720.1 ENST00000531067.1 ENST00000533290.1 ENST00000529499.1 ENST00000529946.1 ENST00000526005.1 ENST00000395288.2 ENST00000534239.1 |
KBTBD4 |
kelch repeat and BTB (POZ) domain containing 4 |
chr19_+_41856816 | 0.28 |
ENST00000539627.1 |
TMEM91 |
transmembrane protein 91 |
chr3_+_63953415 | 0.28 |
ENST00000484332.1 |
ATXN7 |
ataxin 7 |
chr6_-_43276535 | 0.27 |
ENST00000372569.3 ENST00000274990.4 |
CRIP3 |
cysteine-rich protein 3 |
chr1_+_146373546 | 0.27 |
ENST00000446760.2 |
NBPF12 |
neuroblastoma breakpoint family, member 12 |
chr2_+_204192942 | 0.27 |
ENST00000295851.5 ENST00000261017.5 |
ABI2 |
abl-interactor 2 |
chr2_+_201994208 | 0.27 |
ENST00000440180.1 |
CFLAR |
CASP8 and FADD-like apoptosis regulator |
chr12_-_58329888 | 0.27 |
ENST00000546580.1 |
RP11-620J15.3 |
RP11-620J15.3 |
chr12_-_71551652 | 0.27 |
ENST00000546561.1 |
TSPAN8 |
tetraspanin 8 |
chr9_-_13165457 | 0.27 |
ENST00000542239.1 ENST00000538841.1 ENST00000433359.2 |
MPDZ |
multiple PDZ domain protein |
chr5_+_43602750 | 0.26 |
ENST00000505678.2 ENST00000512422.1 ENST00000264663.5 |
NNT |
nicotinamide nucleotide transhydrogenase |
chr5_+_118812294 | 0.26 |
ENST00000509514.1 |
HSD17B4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
chr17_-_5389477 | 0.26 |
ENST00000572834.1 ENST00000570848.1 ENST00000571971.1 ENST00000158771.4 |
DERL2 |
derlin 2 |
chr19_+_16059818 | 0.26 |
ENST00000322107.1 |
OR10H4 |
olfactory receptor, family 10, subfamily H, member 4 |
chr11_-_124981475 | 0.26 |
ENST00000532156.1 ENST00000532407.1 ENST00000279968.4 ENST00000527766.1 ENST00000529583.1 ENST00000524373.1 ENST00000527271.1 ENST00000526175.1 ENST00000529609.1 ENST00000533273.1 ENST00000531909.1 ENST00000529530.1 |
TMEM218 |
transmembrane protein 218 |
chr7_-_26904317 | 0.26 |
ENST00000345317.2 |
SKAP2 |
src kinase associated phosphoprotein 2 |
chr19_+_39759154 | 0.26 |
ENST00000331982.5 |
IFNL2 |
interferon, lambda 2 |
chr5_+_72112470 | 0.26 |
ENST00000447967.2 ENST00000523768.1 |
TNPO1 |
transportin 1 |
chr4_-_52883786 | 0.25 |
ENST00000343457.3 |
LRRC66 |
leucine rich repeat containing 66 |
chr6_+_132873832 | 0.25 |
ENST00000275200.1 |
TAAR8 |
trace amine associated receptor 8 |
chr11_-_12030629 | 0.25 |
ENST00000396505.2 |
DKK3 |
dickkopf WNT signaling pathway inhibitor 3 |
chr11_-_47600549 | 0.25 |
ENST00000430070.2 |
KBTBD4 |
kelch repeat and BTB (POZ) domain containing 4 |
chr1_-_155177677 | 0.25 |
ENST00000368378.3 ENST00000541990.1 ENST00000457183.2 |
THBS3 |
thrombospondin 3 |
chrX_-_13835147 | 0.25 |
ENST00000493677.1 ENST00000355135.2 |
GPM6B |
glycoprotein M6B |
chr1_+_151512775 | 0.25 |
ENST00000368849.3 ENST00000392712.3 ENST00000353024.3 ENST00000368848.2 ENST00000538902.1 |
TUFT1 |
tuftelin 1 |
chr16_-_54963026 | 0.25 |
ENST00000560208.1 ENST00000557792.1 |
CRNDE |
colorectal neoplasia differentially expressed (non-protein coding) |
chrX_+_102631844 | 0.25 |
ENST00000372634.1 ENST00000299872.7 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chr11_-_33757950 | 0.25 |
ENST00000533403.1 ENST00000528700.1 ENST00000527577.1 ENST00000395850.3 ENST00000351554.3 |
CD59 |
CD59 molecule, complement regulatory protein |
chr12_-_49582978 | 0.25 |
ENST00000301071.7 |
TUBA1A |
tubulin, alpha 1a |
chr5_-_133510456 | 0.25 |
ENST00000520417.1 |
SKP1 |
S-phase kinase-associated protein 1 |
chr1_+_99127225 | 0.24 |
ENST00000370189.5 ENST00000529992.1 |
SNX7 |
sorting nexin 7 |
chr16_-_18887627 | 0.24 |
ENST00000563235.1 |
SMG1 |
SMG1 phosphatidylinositol 3-kinase-related kinase |
chr3_+_108321623 | 0.24 |
ENST00000497905.1 ENST00000463306.1 |
DZIP3 |
DAZ interacting zinc finger protein 3 |
chr1_+_52521797 | 0.24 |
ENST00000313334.8 |
BTF3L4 |
basic transcription factor 3-like 4 |
chr17_+_53343577 | 0.24 |
ENST00000573945.1 |
HLF |
hepatic leukemia factor |
chr11_-_67141090 | 0.24 |
ENST00000312438.7 |
CLCF1 |
cardiotrophin-like cytokine factor 1 |
chr15_+_65914260 | 0.24 |
ENST00000261892.6 ENST00000339868.6 |
SLC24A1 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 1 |
chr2_-_97405775 | 0.23 |
ENST00000264963.4 ENST00000537039.1 ENST00000377079.4 ENST00000426463.2 ENST00000534882.1 |
LMAN2L |
lectin, mannose-binding 2-like |
chr1_-_113161730 | 0.23 |
ENST00000544629.1 ENST00000543570.1 ENST00000360743.4 ENST00000490067.1 ENST00000343210.7 ENST00000369666.1 |
ST7L |
suppression of tumorigenicity 7 like |
chr5_-_88178964 | 0.23 |
ENST00000513252.1 ENST00000508569.1 ENST00000510942.1 ENST00000506554.1 |
MEF2C |
myocyte enhancer factor 2C |
chr6_-_146057144 | 0.23 |
ENST00000367519.3 |
EPM2A |
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) |
chr6_+_6588902 | 0.23 |
ENST00000230568.4 |
LY86 |
lymphocyte antigen 86 |
chr17_-_58603568 | 0.23 |
ENST00000083182.3 |
APPBP2 |
amyloid beta precursor protein (cytoplasmic tail) binding protein 2 |
chr1_-_169599353 | 0.23 |
ENST00000367793.2 ENST00000367794.2 ENST00000367792.2 ENST00000367791.2 ENST00000367788.2 |
SELP |
selectin P (granule membrane protein 140kDa, antigen CD62) |
chr10_-_7453445 | 0.22 |
ENST00000379713.3 ENST00000397167.1 ENST00000397160.3 |
SFMBT2 |
Scm-like with four mbt domains 2 |
chr19_+_36132631 | 0.22 |
ENST00000379026.2 ENST00000379023.4 ENST00000402764.2 ENST00000479824.1 |
ETV2 |
ets variant 2 |
chr1_-_68698197 | 0.22 |
ENST00000370973.2 ENST00000370971.1 |
WLS |
wntless Wnt ligand secretion mediator |
chr3_-_98241713 | 0.22 |
ENST00000502288.1 ENST00000512147.1 ENST00000510541.1 ENST00000503621.1 ENST00000511081.1 |
CLDND1 |
claudin domain containing 1 |
chr15_+_75498739 | 0.22 |
ENST00000565074.1 |
C15orf39 |
chromosome 15 open reading frame 39 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.6 | 3.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.3 | 0.8 | GO:2000276 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.2 | 1.1 | GO:0038190 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.2 | 0.8 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 1.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.2 | 1.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 1.0 | GO:0048749 | compound eye development(GO:0048749) |
0.2 | 2.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.2 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 0.5 | GO:1901297 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.2 | 0.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.7 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 0.7 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular response to UV-A(GO:0071492) |
0.1 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 1.3 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 1.3 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.5 | GO:0032848 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.1 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.1 | 1.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.1 | 0.5 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.4 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.1 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0042223 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
0.1 | 0.3 | GO:2000777 | positive regulation of oocyte maturation(GO:1900195) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.8 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.4 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 0.5 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 1.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.7 | GO:1990034 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export from cell(GO:1990034) |
0.1 | 0.3 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.1 | 0.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.1 | 1.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 1.5 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 0.5 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.3 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 1.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.3 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 4.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.4 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 1.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.4 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.2 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.2 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.0 | 2.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.2 | GO:1901895 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.0 | 0.6 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.0 | 0.0 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.0 | 0.2 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.3 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.2 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.0 | 0.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.5 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 1.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.6 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.0 | 0.2 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
0.0 | 0.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.9 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.1 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.0 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.2 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.0 | 0.5 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.0 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.2 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.0 | 0.1 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
0.0 | 0.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 1.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.2 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.6 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.4 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.2 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.6 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.1 | GO:0035701 | immunoglobulin biosynthetic process(GO:0002378) hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.2 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.8 | GO:0032259 | methylation(GO:0032259) |
0.0 | 0.0 | GO:2000532 | cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) regulation of metanephric mesenchymal cell migration(GO:2000589) |
0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.4 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.2 | GO:0070269 | pyroptosis(GO:0070269) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.3 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 1.2 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.9 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.4 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.0 | 0.1 | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090100) |
0.0 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.3 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.9 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.0 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.6 | GO:0021762 | substantia nigra development(GO:0021762) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 4.8 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.3 | 3.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 2.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 0.9 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.4 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.9 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 4.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 1.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 1.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
0.1 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.0 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.0 | 0.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 2.0 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 0.2 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.1 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.0 | 3.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 2.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.6 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.4 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.0 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.2 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 1.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.5 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.9 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.4 | 1.5 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.2 | 1.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.2 | 0.6 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.2 | 0.9 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.5 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.2 | 1.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 3.9 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.1 | 1.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.3 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.1 | 0.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 0.3 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 0.5 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 0.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 2.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 2.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.4 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 1.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.7 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.0 | 0.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.2 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.0 | 1.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 5.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 1.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 3.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 1.0 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 1.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.1 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 2.1 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.1 | GO:0047708 | biotinidase activity(GO:0047708) |
0.0 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 2.6 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 1.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 9.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 1.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 1.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 1.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 1.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 4.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID ARF6 PATHWAY | Arf6 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 9.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 2.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 1.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 3.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 1.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |